Alberto Chiappori

Author PubWeight™ 0.90^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Phase II, double-blinded, randomized study of enzastaurin plus pemetrexed as second-line therapy in patients with advanced non-small cell lung cancer.	J Thorac Oncol	2010	0.90